AIM ImmunoTech (AIM) Stock: Buy, Sell, or Hold?
$0.15
+0.00 (+0.13%)
▲
5d:
-2.3%
30d:
-8.16%
90d:
-32.42%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (83%)
Quality Score
54/100
Position
OVERSOLD
30-Day Fair Range
$0.15 – $0.18
Position: OVERSOLD
Forward P/E & Valuation
-0.4x
Next 12M consensus est.
Wall Street Target
$4.25
+2760.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.12 / $0.17
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.15, which is considered oversold relative to its 30-day fair value range of $0.15 to $0.18.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.17.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.25 (+2760.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.17.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.25 (+2760.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.15 -
$0.18
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$0.15 -
$0.18
Current vs Trading Range
OVERSOLD
Support Level
$0.12
Resistance Level
$0.17
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2760.0% below Wall St target ($4.25)
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-0.40
Wall Street Target
$4.25
(+2760.0%)
Revenue Growth (YoY)
4.0%
Share AIM Analysis
Share this live AIM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AIM)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
CEO insider buying of $AIM stock was met with mixed sentiment on StockTwits, while no recent news articles were available.
Key Retail Themes:
CEO insider buying
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:36 AM ET
Data refreshes hourly during market hours. Next update: 5:36 AM
Data refreshes hourly during market hours. Next update: 5:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$42 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AIM Research Pages
